marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Abeona Therapeutics Financial Ratios 2011-2024 | ABEO
Annual Financial Ratios Abeona Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-2.8 | -0.6 | -0.0 | -2.1 | -1.6 | -5.5 | -23.3 | -7.2 | -5.0 | -0.2 | 2.0 | -1.1 | -10.7 |
P/S |
42.7 | 15.5 | 0.3 | 17.7 | - | 104.5 | 761.1 | 176.9 | 69.3 | 6.6 | 4.5 | 2.6 | 14.6 |
EPS |
-2.5 | -5.5 | -21.6 | -0.9 | -1.5 | -1.2 | -0.7 | -0.6 | -0.5 | -15.3 | 3.1 | -0.5 | -0.2 |
EV (Enterprise Value) |
184 M | 45.2 M | 5.3 M | 213 M | 35 M | 335 M | 508 M | 100 M | 44.2 M | 6.35 M | 24.1 M | 29.8 M | 45.9 M |
EBITDA per Share |
-2.1 | -6.08 | -22 | -0.474 | -1.38 | -1.17 | -0.651 | -0.675 | -0.652 | -1.61 | -7.53 | -8.06 | -19.1 |
EV/EBITDA |
0.1 | -3.8 | 0.1 | -5.8 | -18.4 | -3.8 | -2.0 | 0.3 | -2.3 | -2.8 | -3.6 | ||
PEG |
-0.0 | -0.0 | -0.0 | -0.05 | 0.06 | 0.07 | 7.46 | 0.35 | -0.05 | 0.0 | 0.02 | 0.01 | -0.17 |
P/B |
10.1 | 0.8 | 0.0 | 1.7 | 0.7 | 2.3 | 3.7 | 1.6 | 1.1 | 1.3 | -0.6 | -0.7 | -1.5 |
P/CF |
-4.0 | -0.5 | -0.0 | -4.9 | -1.7 | -5.3 | -26.8 | -11.6 | -6.7 | -3.8 | -9087.5 | -2.9 | -3.5 |
ROE % |
-365.49 | -148.34 | -200.47 | -82.14 | -42.75 | -42.28 | -16.06 | -22.07 | -21.45 | -556.02 | -30.10 | 61.68 | 14.38 |
ROA % |
-84.67 | -61.82 | -106.72 | -55.71 | -34.15 | -32.50 | -15.28 | -19.70 | -18.15 | -161.49 | 725.77 | -608.79 | -66.90 |
ROCE % |
-317.92 | -190.26 | -212.04 | -44.40 | -41.74 | -37.76 | -16.08 | -23.24 | -23.60 | -22.88 | 45.57 | 88.10 | 93.71 |
Current Ratio |
1.3 | 1.7 | 2.1 | 2.3 | 3.4 | 4.4 | 25.1 | 8.4 | 27.5 | 4.0 | 0.1 | 0.3 | 0.3 |
DSO |
- | 387.2 | 182.5 | - | - | 9.9 | 46.7 | 50.9 | 40.4 | 13.8 | 13.2 | 69.6 | 65.8 |
DIO |
- | - | - | - | - | - | - | - | - | - | - | 265.2 | 45.3 |
DPO |
- | - | - | - | - | - | - | - | - | - | 2520.0 | 2787.4 | 514.2 |
Operating Cycle |
- | 387.2 | 182.5 | - | - | - | - | - | - | - | 13.2 | 334.8 | 111.1 |
Cash Conversion Cycle |
- | 387.2 | 182.5 | - | - | - | - | - | - | - | -2506.7 | -2452.6 | -403.1 |
All numbers in USD currency
Quarterly Financial Ratios Abeona Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.63 | 0.19 | -1.16 | - | -0.48 | -0.92 | -0.54 | - | -1 | 1.36 | -3.8 | - | -1.8 | -3.93 | -0.17 | - | -0.08 | -0.14 | -0.52 | -0.3 | -0.35 | -0.49 | -0.39 | -0.36 | -0.34 | -0.26 | -0.22 | -0.19 | -0.13 | -0.21 | -0.13 | - | -0.08 | -0.2 | -0.17 | - | -0.19 | -0.16 | -0.1 | - | -4.15 | -0.51 | -0.03 | - | -1.77 | 0.03 | 0.14 | - | -0.63 | -0.46 | -0.22 | - | - | -0.09 | -0.12 |
EBITDA per Share |
-0.31 | -0.43 | -0.51 | - | -0.44 | -0.55 | -0.67 | - | -1.34 | -1.24 | -3.41 | - | -3.17 | -3.12 | -0.15 | - | -0.06 | -0.13 | -0.5 | -0.3 | -0.31 | -0.45 | -0.36 | -0.38 | -0.34 | -0.26 | -0.22 | -0.19 | -0.13 | -0.2 | -0.13 | - | -0.15 | -0.2 | -0.18 | - | -0.19 | -0.16 | -0.09 | - | -1.19 | -0.03 | -0.05 | - | -1.37 | -0.08 | -0.02 | - | -0.04 | -0.06 | -0.03 | - | -0.09 | -0.11 | -0.11 |
ROE % |
245.84 | 258.27 | 69.94 | -280.52 | -332.40 | -330.58 | -181.58 | -185.16 | -193.99 | -150.95 | -139.82 | -43.87 | -50.93 | -49.15 | -43.75 | -66.70 | -75.91 | -78.59 | -79.31 | -42.75 | -46.58 | -49.10 | -44.82 | -42.28 | -34.21 | -25.10 | -20.83 | -16.06 | -13.74 | -13.25 | -15.14 | -15.01 | -23.97 | -30.29 | -29.60 | -17.99 | -48.50 | -70.03 | -323.66 | -308.04 | -306.97 | -275.41 | -26.54 | -37.38 | 49.69 | 135.69 | 208.59 | 177.79 | 175.80 | 86.75 | 31.85 | 15.98 | -1.99 | 7.18 | 10.79 |
ROA % |
-79.68 | -72.49 | -109.12 | -66.08 | -82.68 | -81.37 | -59.43 | -65.72 | -71.63 | -60.95 | -63.43 | -28.87 | -33.66 | -32.52 | -29.49 | -45.24 | -52.60 | -55.59 | -57.69 | -34.15 | -36.82 | -38.45 | -34.76 | -32.50 | -27.20 | -20.77 | -18.38 | -15.28 | -12.92 | -12.29 | -13.70 | -13.39 | -20.98 | -26.20 | -25.30 | -15.22 | -24.08 | -25.35 | -95.64 | -89.46 | -115.08 | -131.83 | 204.61 | 901.14 | 41.78 | -791.97 | -1665.70 | -1754.86 | -1745.61 | -877.00 | -297.68 | -74.32 | 9.25 | -33.39 | -50.17 |
ROCE % |
52.01 | 34.11 | -54.44 | -228.60 | -304.24 | -328.45 | -272.62 | -229.95 | -248.60 | -191.61 | -150.82 | -50.42 | -56.52 | -43.96 | -39.82 | -65.27 | -74.47 | -78.27 | -79.54 | -43.20 | -47.44 | -50.17 | -46.10 | -43.39 | -35.10 | -25.63 | -21.23 | -16.36 | -16.44 | -18.51 | -20.32 | -18.21 | -27.32 | -31.20 | -30.51 | -18.15 | -31.30 | -35.34 | -43.84 | -55.32 | -50.61 | -32.75 | -5.16 | 21.11 | 26.71 | 27.60 | 23.10 | 18.14 | 28.27 | 32.80 | 37.10 | 35.14 | 10.13 | 12.80 | 12.21 |
Current Ratio |
1.6 | 2.2 | 0.9 | 1.3 | 1.5 | 1.2 | 1.5 | 1.7 | 1.7 | 1.8 | 2.3 | 2.8 | 3.0 | 2.8 | 3.0 | 3.1 | 3.1 | 3.1 | 3.1 | 5.0 | 5.0 | 5.0 | 5.0 | 4.3 | 4.3 | 4.3 | 4.3 | 20.6 | 20.6 | 20.6 | 20.6 | 9.3 | 9.3 | 9.3 | 9.3 | 6.5 | 6.5 | 6.5 | 6.5 | 1.4 | 1.4 | 1.4 | 1.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 |
DSO |
- | - | - | - | - | - | - | - | 69.4 | 45.6 | 395.6 | - | - | - | - | - | 45.6 | - | - | - | - | - | - | - | 4.3 | 26.8 | 3.3 | - | 44.6 | 45.0 | 56.7 | - | 61.5 | 52.9 | 46.4 | - | 36.8 | 37.2 | 26.5 | - | 13.5 | 12.9 | 23.9 | - | 35.7 | 14.5 | 34.1 | - | 88.0 | 111.1 | 29.1 | - | 29.2 | 202.6 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | 69.4 | 45.6 | 395.6 | - | - | - | - | - | 45.6 | - | - | - | - | - | - | - | 4.3 | 26.8 | 3.3 | - | 44.6 | 45.0 | 56.7 | - | 61.5 | 52.9 | 46.4 | - | 36.8 | 37.2 | 26.5 | - | 13.5 | 12.9 | 23.9 | - | 35.7 | 14.5 | 34.1 | - | 88.0 | 111.1 | 29.1 | - | 29.2 | 202.6 | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | 69.4 | 45.6 | 395.6 | - | - | - | - | - | 45.6 | - | - | - | - | - | - | - | 4.3 | 26.8 | 3.3 | - | 44.6 | 45.0 | 56.7 | - | 61.5 | 52.9 | 46.4 | - | 36.8 | 37.2 | 26.5 | - | 13.5 | 12.9 | 23.9 | - | 35.7 | 14.5 | 34.1 | - | 88.0 | 111.1 | 29.1 | - | 29.2 | 202.6 | - |
All numbers in USD currency